Pertussis toxin suppresses carbachol-evoked cardiodepression but does not modify cardiostimulation mediated through beta(1)- and putative beta(4)-adrenoceptors in mouse left atria: no evidence for beta(2)- and beta(3)-adrenoceptor function
J. Oostendorp et Aj. Kaumann, Pertussis toxin suppresses carbachol-evoked cardiodepression but does not modify cardiostimulation mediated through beta(1)- and putative beta(4)-adrenoceptors in mouse left atria: no evidence for beta(2)- and beta(3)-adrenoceptor function, N-S ARCH PH, 361(2), 2000, pp. 134-145
Activation of beta(1)-, beta(2)-, beta(3)- and putative beta(4)-adrenocepto
rs modifies cardiac function. These receptors are usually coupled to G(s) p
rotein, but beta(2)- and beta(3)-adrenoceptors could also couple to G(i/o)
proteins. The mouse heart is used increasingly for studies of genetically d
isrupted or overexpressed proteins, including beta-adrenoceptor subtypes. W
e therefore investigated in contracting mouse left atria (2 Hz, 37 degrees
C) if inactivation of G(i/o) proteins with pertussis toxin modifies or unco
vers effects mediated through beta-adrenoceptor subtypes. The negative inot
ropic effects of carbachol in atria exposed to catecholamine or high calciu
m (6.8 mmol/l) were assumed to be mediated through activation of muscarinic
receptors coupled to G(i/o). We report conditions under which incubation o
f left atria with 200 ng/ml pertussis toxin for 24 h nearly abolished the c
arbachol responses. Although it has been reported that muscarinic receptor-
mediated cardiodepression has an obligatory contribution of nitric oxide, t
he nitric oxide synthase inhibitor N-G-monomethyl-L-arginine (0.1-1 mmol/l)
did not modify the negative inotropic effects of carbachol, inconsistent w
ith an involvement of nitric oxide. The positive inotropic effects of (-)-n
oradrenaline and (-)-adrenaline, mediated through beta(1)-adrenoceptors, we
re not affected by pertussis toxin. (-)-Adrenaline did not cause positive i
notropic effects attributable to beta(2)-adrenoceptor-mediation, in the pre
sence of CGP 20712A (300 nmol/l) to block beta(1)-adrenoceptors, in control
atria or atria pretreated with pertussis toxin. The positive inotropic eff
ects of (-)-CGP 12177 (1 mu mol/l), a compound with agonist activity at the
putative beta(4)-adrenoceptor, were unaffected by pertussis toxin. The bet
a(3)-adrenoceptor-selective agonist BRL 37344 (1 mu mol/l), in the presence
of (-)-propranolol (200 nmol/l), did not cause positive or negative inotro
pic effects in control and pertussis toxin-treated atria. In left atria obt
ained from mice injected with 150 mu g/kg i.p. pertussis toxin which abolis
hed carbachol-evoked cardiodepression, the positive inotropic effects of (-
)-adrenaline were antagonised by CGP 20712A. The beta(2)-adrenoceptor-selec
tive antagonist ICI 118551 (50 nmol/l) did not cause additional blockade of
the effects of high (-)-adrenaline concentrations in the presence of CGP 2
0712A, ruling out the involvement of beta(2)-adrenoceptors. The results wit
h intraparenteral PTX validate our in vitro PTX method. We conclude that in
hibition of murine G(i/o) proteins does not alter atrial positive inotropic
effects mediated through beta(1)- and putative beta(4)-adrenoceptors and d
oes not reveal functional beta(2)- and beta(3)-adrenoceptors.